Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis from the broad-spectrum approach of chemotherapy to prompting the immune system’s boldest warriors—its T cells—to target only the infiltrating tumor.
Continue Reading this article here
